Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Sarcoma, Ewing × rubitecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1

Interventions

Irinotecan 6 Temozolomide 5 PM 01183 3 Nivolumab 3 X-Rays 2 Vincristine 2 Cyclophosphamide 2 temsirolimus 1 talazoparib 1 surufatinib 1 silmitasertib 1 seclidemstat 1 rubitecan 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 eribulin 1 entrectinib 1 efineptakin alfa 1 dinutuximab 1 copanlisib 1 bempegaldesleukin 1 anlotinib 1 alovudine 1 abemaciclib 1 Zoledronic Acid 1 Trabectedin 1 Topotecan 1 TQ-B3525 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00492141 2012-08-02

Aerosol L9-NC and Temozolomide in Ewing's Sarcoma

M.D. Anderson Cancer Center

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡